Pacific Biosciences of California (PACB)
(Delayed Data from NSDQ)
$1.28 USD
+0.05 (4.07%)
Updated Sep 18, 2025 04:00 PM ET
After-Market: $1.28 0.00 (0.00%) 7:22 PM ET
3-Hold of 5 3
F Value A Growth C Momentum C VGM
Fundamental Charts
About Dividend Yield (TTM)
Pacific Biosciences of California, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Instruments industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
PACB 1.28 +0.05(4.07%)
Will PACB be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for PACB based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PACB
Why Pacific Biosciences of California (PACB) Dipped More Than Broader Market Today
PACB Partners With EpiCypher to Advance Epigenomics Using Fiber-Seq
PACB: What are Zacks experts saying now?
Zacks Private Portfolio Services
PacBio Stock Up on Q2 Earnings & Revenue Beat Estimates, Margin Rises
Pacific Biosciences (PACB) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Pacific Biosciences of California (PACB) Reports Q2 Loss, Beats Revenue Estimates
Other News for PACB
Sideways movement on September 17 results in no shift to PACB’s technical outlook
Technical picture remains unchanged for PACB after it rises 2.5% on September 16
Technical picture remains unchanged for PACB after it rises 2.56% on September 15
PACB falls 7.14% on September 12, leaving the technical picture intact
The technical outlook for PACB is unchanged after it rises 3.28% on September 11